# Willingness of patients with chronic diseases to use telepharmacy services in Bandung City, West Java, Indonesia

**Authors:** Sofa D. Alfian, Qisty A. Khoiry, Meliana Griselda, Ivan S. Pradipta, Nursiswati Nursiswati, Rizky Abdulah

PMC · DOI: 10.1038/s41598-025-09688-3 · Scientific Reports · 2025-07-11

## TL;DR

This study explores how willing patients with chronic diseases in Bandung, Indonesia, are to use telepharmacy services and finds that willingness is low, especially among older patients and those with limited internet skills.

## Contribution

The study identifies specific patient-related factors associated with low willingness to adopt telepharmacy in a region where such services were not well-established before the pandemic.

## Key findings

- Current practices and willingness to use telepharmacy services among patients with chronic diseases in Bandung are low.
- Older age, inability to use the internet, and limited smartphone usage are significantly associated with low willingness to use telepharmacy services.
- Daily phone usage of less than an hour is linked to a higher likelihood of low willingness to adopt telepharmacy.

## Abstract

The COVID-19 is known to be a severe pandemic that has accelerated the adoption of telepharmacy services. However, little is known about the current practices and willingness of patients with chronic diseases in the new-norm, specifically in a setting where such services are not properly established before the pandemic. The main objective of this study was to assess the current practices and willingness to use telepharmacy services as well as to identify factors associated with low willingness among patients with chronic diseases in Bandung City in Indonesia. A multisite cross-sectional survey was conducted in seven community health centers (CHCs) and one hospital in Bandung City, in Indonesia, which were selected based on the highest number of patients with chronic diseases. The survey utilized a purposive sampling method among patients with hypertension, dyslipidemia, diabetes, chronic obstructive pulmonary diseases (COPD), and/or chronic kidney diseases. Current practices and willingness to use telepharmacy services were evaluated through a paper-based questionnaire. Binary logistic regression analyses were performed to determine factors associated with low willingness to use telepharmacy services. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported. A total of 443 patients with chronic diseases were participated, with most having hypertension. Overall, both current practices and willingness to use telepharmacy services were low. Factors associated with low willingness included being 50 years or older (OR = 3.41; 95%CI = 1.46–7.97), inability to use the internet (OR = 3.92; 95% CI = 1.12–13.76), using smartphones independently (OR = 3.64; 95% CI = 1.13–11.72) or with assistance (OR = 6.75; 95% CI = 1.47–31.07), and daily phone usage of less than an hour (OR = 5.50; 95% CI = 1.08–27.89). The study indicated low practices and willingness to use telepharmcy services among patients with chronic diseases. As a result, patients-specific factors such as older age, inability to use the internet, as well as low daily use of smartphones that associated with the low willingness to use telepharmacy services should be considered in order to facilitate telepharmacy implementation in Indonesia.

The online version contains supplementary material available at 10.1038/s41598-025-09688-3.

## Linked entities

- **Diseases:** dyslipidemia (MONDO:0002525), diabetes (MONDO:0005015)

## Full-text entities

- **Diseases:** chronic kidney diseases (MESH:D051436), COVID-19 (MESH:D000086382), dyslipidemia (MESH:D050171), chronic diseases (MESH:D002908), diabetes (MESH:D003920), COPD (MESH:D029424), hypertension (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12254323/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12254323/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12254323/full.md

---
Source: https://tomesphere.com/paper/PMC12254323